BRCA1-BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes

Nucleic Acids Res. 2023 Nov 10;51(20):11080-11103. doi: 10.1093/nar/gkad793.

Abstract

Chromatin association of the BRCA1-BARD1 heterodimer is critical to promote homologous recombination repair of DNA double-strand breaks (DSBs) in S/G2. How the BRCA1-BARD1 complex interacts with chromatin that contains both damage induced histone H2A ubiquitin and inhibitory H4K20 methylation is not fully understood. We characterised BRCA1-BARD1 binding and enzymatic activity to an array of mono- and di-nucleosome substrates using biochemical, structural and single molecule imaging approaches. We found that the BRCA1-BARD1 complex preferentially interacts and modifies di-nucleosomes over mono-nucleosomes, allowing integration of H2A Lys-15 ubiquitylation signals with other chromatin modifications and features. Using high speed- atomic force microscopy (HS-AFM) to monitor how the BRCA1-BARD1 complex recognises chromatin in real time, we saw a highly dynamic complex that bridges two nucleosomes and associates with the DNA linker region. Bridging is aided by multivalent cross-nucleosome interactions that enhance BRCA1-BARD1 E3 ubiquitin ligase catalytic activity. Multivalent interactions across nucleosomes explain how BRCA1-BARD1 can recognise chromatin that retains partial di-methylation at H4 Lys-20 (H4K20me2), a parental histone mark that blocks BRCA1-BARD1 interaction with nucleosomes, to promote its enzymatic and DNA repair activities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA1 Protein* / chemistry
  • BRCA1 Protein* / metabolism
  • Chromatin* / chemistry
  • Chromatin* / metabolism
  • HeLa Cells
  • Histones / metabolism
  • Humans
  • Nucleosomes*
  • Tumor Suppressor Proteins / genetics
  • Ubiquitin-Protein Ligases* / chemistry
  • Ubiquitin-Protein Ligases* / metabolism

Substances

  • BARD1 protein, human
  • BRCA1 Protein
  • BRCA1 protein, human
  • Chromatin
  • Histones
  • Nucleosomes
  • Tumor Suppressor Proteins
  • Ubiquitin-Protein Ligases